| 1 |
Diakite M, Shaw-saliba K, Lau C. Malignancy and viral infections in Sub-Saharan Africa: A review. Front Virol 2023;3. [DOI: 10.3389/fviro.2023.1103737] [Reference Citation Analysis]
|
| 2 |
Adjei CA, Stutterheim SE, Bram F, Naab F, Ruiter RAC. Correlates of hepatitis B testing in Ghana: The role of knowledge, stigma endorsement and knowing someone with hepatitis B. Health Soc Care Community 2022;30:e4564-73. [PMID: 35701984 DOI: 10.1111/hsc.13860] [Reference Citation Analysis]
|
| 3 |
Maepa MB, Ely A, Kramvis A, Bloom K, Naidoo K, Simani OE, Maponga TG, Arbuthnot P. Hepatitis B Virus Research in South Africa. Viruses 2022;14:1939. [DOI: 10.3390/v14091939] [Reference Citation Analysis]
|
| 4 |
Flores JE, Thompson AJ, Ryan M, Howell J. The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma. Vaccines 2022;10:793. [DOI: 10.3390/vaccines10050793] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 5 |
Coste M, Badji MA, Diallo A, Mora M, Boyer S, Prah JJ. Applying the health capability profile to empirically study chronic hepatitis B in rural Senegal: a social justice mixed-methods study protocol. BMJ Open 2022;12:e055957. [PMID: 35410929 DOI: 10.1136/bmjopen-2021-055957] [Reference Citation Analysis]
|
| 6 |
Dionne-Odom J, Cozzi GD, Franco RA, Njei B, Tita ATN. Treatment and prevention of viral hepatitis in pregnancy. Am J Obstet Gynecol 2022;226:335-46. [PMID: 34516961 DOI: 10.1016/j.ajog.2021.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 7 |
Boisson A, Goel V, Yotebieng M, Parr JB, Fried B, Thompson P. Implementation Approaches for Introducing and Overcoming Barriers to Hepatitis B Birth-Dose Vaccine in sub-Saharan Africa. Glob Health Sci Pract 2022;10:e2100277. [DOI: 10.9745/ghsp-d-21-00277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Ingasia LAO, Wose Kinge C, Kramvis A. Genotype E: The neglected genotype of hepatitis B virus. World J Hepatol 2021; 13(12): 1875-1891 [DOI: 10.4254/wjh.v13.i12.1875] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Quaye T, Narkwa PW, Domfeh SA, Kattah G, Mutocheluh M. Immunosurveillance and molecular detection of hepatitis B virus infection amongst vaccinated children in the West Gonja District in Savanna Region of Ghana. PLoS One 2021;16:e0257103. [PMID: 34534234 DOI: 10.1371/journal.pone.0257103] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Thompson P, Morgan CE, Ngimbi P, Mwandagalirwa K, Ravelomanana NLR, Tabala M, Fathy M, Kawende B, Muwonga J, Misingi P, Mbendi C, Luhata C, Jhaveri R, Cloherty G, Kaba D, Yotebieng M, Parr JB. Arresting vertical transmission of hepatitis B virus (AVERT-HBV) in pregnant women and their neonates in the Democratic Republic of the Congo: a feasibility study. Lancet Glob Health 2021;9:e1600-9. [PMID: 34416175 DOI: 10.1016/S2214-109X(21)00304-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Kramvis A. Challenges for hepatitis B virus cure in resource-limited settings in sub-Saharan Africa. Curr Opin HIV AIDS 2020;15:185-92. [PMID: 32141888 DOI: 10.1097/COH.0000000000000619] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 12 |
Tamandjou Tchuem CR, Andersson MI, Wiysonge CS, Mufenda J, Preiser W, Cleary S. Prevention of hepatitis B mother-to-child transmission in Namibia: A cost-effectiveness analysis. Vaccine 2021;39:3141-51. [PMID: 33962836 DOI: 10.1016/j.vaccine.2021.04.041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 13 |
Doran Brubaker S, Ward JW, Hiebert L, Morgan RL. Developing an Evidence Base for the Delivery of Hepatitis B Virus Birth Dose Vaccination: An Evidence Map and Critical Appraisal of Systematic Reviews and Guidelines. Clin Liver Dis (Hoboken) 2021;17:375-81. [PMID: 34136145 DOI: 10.1002/cld.1103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 14 |
Mutyoba JN, Surkan PJ, Makumbi F, Aizire J, Kirk GD, Ocama P, Atuyambe LM. Hepatitis B birth dose vaccination for newborns in Uganda: A qualitative inquiry on pregnant women's perceptions, barriers and preferences. J Virus Erad 2021;7:100039. [PMID: 34026246 DOI: 10.1016/j.jve.2021.100039] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 15 |
Thompson P, Morgan CE, Ngimbi P, Mwandagalirwa K, Ravelomanana N, Tabala M, Fathy M, Kawende B, Muwonga J, Misingi P, Mbendi C, Luhata C, Jhaveri R, Cloherty G, Kaba D, Yotebieng M, Parr JB. Arresting Vertical Transmission of Hepatitis B Virus (AVERT-HBV) in the Democratic Republic of the Congo.. [DOI: 10.1101/2021.03.19.21253929] [Reference Citation Analysis]
|
| 16 |
Bierhoff M, Angkurawaranon C, Rijken MJ, Sriprawa K, Kobphan P, Nosten FN, van Vugt M, McGready R, Devine A. Tenofovir disoproxil fumarate in pregnancy for prevention of mother to child transmission of hepatitis B in a rural setting on the Thailand-Myanmar border: a cost-effectiveness analysis. BMC Pregnancy Childbirth 2021;21:157. [PMID: 33618698 DOI: 10.1186/s12884-021-03612-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 17 |
Oliveira D, Martins MDR, Castro R, Cordeiro L, Barroso MR, Nazaré MA, Pereira F. Seropositivity rate and sociodemographic factors associated to HIV, HBV, HCV and syphilis among parturients from Irene Neto Maternity of Lubango city, Angola. Sex Transm Infect 2020;96:587-9. [PMID: 32423945 DOI: 10.1136/sextrans-2019-054249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 18 |
Jorge AS, Horvath BS, Ariati C, Silva JC, Lima LB, Horvath JD, Teixeira JJV, Bertolini DA. Hepatitis B prophylaxis in newborns: A cross-sectional study of 7-year attendance in a public hospital of Brazil. Am J Infect Control 2019;47:1107-11. [PMID: 31027941 DOI: 10.1016/j.ajic.2019.03.008] [Reference Citation Analysis]
|
| 19 |
Zhang Z, Wang C, Liu Z, Zou G, Li J, Lu M. Host Genetic Determinants of Hepatitis B Virus Infection. Front Genet. 2019;10:696. [PMID: 31475028 DOI: 10.3389/fgene.2019.00696] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 20 |
Kowo MP, Yimagou EK, Andoulo FA, Ndam AWN, Jemea B, Bagnaka SAFE, Guekam PO, Pessidjo L, Leuwat ET, Noah DN, Njoya O. Clinical Aspects and Precipitating Factors of Hepatic Encephalopathy Associated with Cirrhosis in a Cameroonian Population. OJGas 2019;09:228-238. [DOI: 10.4236/ojgas.2019.911026] [Reference Citation Analysis]
|
| 21 |
Jhaveri R. Hot Topics in Viral Infections. Clin Ther 2018;40:1230-3. [PMID: 30093134 DOI: 10.1016/j.clinthera.2018.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 22 |
Shader RI. Zoonotic Viruses: The Mysterious Leap From Animals to Man. Clin Ther 2018;40:1225-7. [PMID: 30055823 DOI: 10.1016/j.clinthera.2018.06.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
